ChargePoint Technology is the trusted sterile and contained transfer specialist. We connect your process, enabling safe and reliable powder transfers.
The first ChargePoint valve was developed in 1997 with Glaxo Pharmaceuticals (now GlaxoSmithKline) and the core features of this valve remain across ChargePoint products today. ChargePoint Technology Ltd was formed over a decade ago following the development of this original valve, and our patented technology has become a pharmaceutical industry standard for high containment powder transfers.
Today, we offer a range of high containment and sterile powder transfer solutions along with extraction and decontamination equipment and cleaning, washing, and handling accessories.
Our solutions are manufactured using FDA compliant materials with full material certification and batch traceability and are manufactured in facilities that conform to ATEX (European Hazardous Area Directive) HazLoc (North America Hazardous Area Directive) and PED (European Pressure Equipment Directive).
Our products provide containment performance and sterility assurance combined with single-use solutions to handle the increasingly potent ingredients used in several sectors including:
- Pharmaceutical powder manufacturing
- Chemical industry powder manufacturing
- Biopharmaceutical products
- Containment solutions
ChargePoint’s containment solutions provide a reduced risk of cross-contamination via closed transfers, ensure the safety of your personnel and provide a dust-free environment when processing toxic powders and high potent APIs.
